FDA Panel Rejects Experimental Diet Pill
FDA Panel Rejects Experimental Diet Pill
A panel of federal health experts dealt a surprising setback to a highly anticipated anti-obesity pill from Vivus Inc., saying the drug’s side effects were too great.
Read more on KETV 7 Omaha